UNSPSC 51293015: Nortriptyline hydrochloride

This classification denotes an adrenergic uptake inhibitor and tricyclic antidepressive agent with the molecular formula C19H21N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00FN6IH15D, chemically known as 10,11-dihydro-n-methyl-5h-dibenzo(a,d)cycloheptene-delta(5,gamma)-propylamine but more generally known as nortriptyline hydrochloride, which bears US NIH Compound Identifier 4543.

UNSPSC 51293015 Nortriptyline hydrochloride is a Commodity code for pharmaceutical products, but the recent state and local procurement activity posted under it reflects a mismatch with the code's nominal scope. Seminole County, Florida solicited naloxone and drug deactivation systems through IFB 60459723LAS—products unrelated to nortriptyline, a tricyclic antidepressant. The code shows little relevant recent activity aligned with its stated pharmaceutical classification.

The single recorded opportunity under this code—Seminole County's IFB for naloxone and safe drug deactivation systems, posted June 30, 2026 with a response deadline of July 26, 2023—appears to reflect a data error or misclassification in the state procurement database rather than genuine solicitation activity for nortriptyline or related antidepressant medications. Bidders were required to supply 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in their bids. Because the posted opportunity does not align with the code's pharmaceutical scope and no additional opportunities supporting nortriptyline procurement appear in the source, this Commodity code does not offer a clear signal for pursuit at this time.